Search

Search Constraints

You searched for: Author/Creator Fielding, A.

Search Results

1. 2759 Management of nausea and vomiting during treatment with the capsule (CAP) and tablet (TAB) formulations of the PARP inhibitor olaparib. (September 2015)

2. 466 Next generation sequencing of BRCA1 and BRCA2 genes in ovarian tumors captures all germline mutations and expands the potential treatment group for the PARP inhibitor olaparib. (September 2015)

3. Compliance of randomised controlled trials in general surgical journals with the CONSORT 2010 statement: A retrospective cohort study and review of the literature. (July 2018)

8. P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS. (23rd June 2022)